Skip to navigation Skip to content

Tech Transfer

The Diabetes Research Group has made a number of research discoveries leading to development of a strong patent portfolio and intellectual property for commercialisation through Innovation Ulster and the establishment of Diabetica Limited.

The establishment of Diabetica Limited was formed by the academic co-founders Professor Peter Flatt, Dr Neville McClenaghan and Professor Finbarr O'Harte.

The co-founders won the prestiguous inaugural ACES Academic Enterprise Award for Innovation in Life Sciences in Stockholm in 2008

The Group contributed two impact case studies in REF2014:

  1. Generation of peptide therapeutics for industry
  2. Development and commercialisation of human clonal beta cells for end-user communities.